PubChem

Medeloop Achieves Milestone with One Million Patient Health Records, Pioneering Advances in Clinical and Translational Research

Retrieved on: 
Monday, April 8, 2024
UCSD, Health informatics, ChEMBL, Patient, Research, Health, PubMed, PubChem, Pharmaceutical industry

This significant achievement underscores the company's dedication to revolutionizing the field of clinical research and confirms the industry's trust in its advanced data analytics capabilities to improve patient care.

Key Points: 
  • This significant achievement underscores the company's dedication to revolutionizing the field of clinical research and confirms the industry's trust in its advanced data analytics capabilities to improve patient care.
  • With this milestone, Medeloop is reaffirming its commitment to leveraging innovative, data-driven solutions to transform patient care and enhance health outcomes on a global scale.
  • This advancement will enable researchers to perform comprehensive analyses, identify trends, and extract vital insights, significantly accelerating the pace of meaningful breakthroughs in healthcare.
  • "We are thrilled to collaborate with Dr. Mike Hogarth to unlock the potential of healthcare data," said CEO Rene Caissie at Medeloop.

ResoluteAI Announces the Integration of New Ontologies, Taxonomies, and Controlled Vocabularies for More Precise Research and Serendipitous Discovery

Retrieved on: 
Wednesday, June 8, 2022
Data Management, Biotechnology, Technology, Health, General Health, Pharmaceutical, Research, Software, Networks, Internet, Science, Online, Ontology, Science, Human, Pharmacovigilance, Disorder, RxNorm, Research, Agriculture, Classification, Food, Catalog, Terminology, PubMed, Tagged, CEO, GO, OMIM, Nebula, Genotype, FDA, National library, Metadata, Knowledge Organization (journal), Phenotype, Gene ontology, Medical dictionary, Medical Subject Headings, Collection, PubChem, MedDRA, SNOMED, Pharmaceutical industry, Medical device, Medicine, Foundation

ResoluteAI, the research platform for science, announced today the integration of seven new ontologies, taxonomies, and controlled vocabularies (OTCVs) to the tagging and classification process on Foundation , its flagship scientific research product.

Key Points: 
  • ResoluteAI, the research platform for science, announced today the integration of seven new ontologies, taxonomies, and controlled vocabularies (OTCVs) to the tagging and classification process on Foundation , its flagship scientific research product.
  • We believe the scientific research process can be significantly enhanced and accelerated by giving users enriched data, said Steve Goldstein, CEO of ResoluteAI.
  • These additional ontologies, taxonomies, and controlled vocabularies will dramatically improve our users research capabilities and increase opportunities for serendipitous scientific discovery, Goldstein continued.
  • Combined with our interactive analytics and downloadable visualizations, ResoluteAI helps make connections that lead to breakthrough discoveries.

CDD Gives Back with Open Access Data Visualization Tool

Retrieved on: 
Thursday, October 7, 2021
SAR, Technology, Drug discovery, Algorithm, GitHub, FAIR, SAN, Open-source model, PubChem, Multimedia, Software, CDD, CDK, Activity, Pfizer, Subversive activities registration, ELN, Policy, Inventory, CEO, Solution, Informatics, Research, View, Online shopping

CDD Visualization is an intuitive browser-based application that allows scientists to visualize their data and generate publication-ready graphs and plots.

Key Points: 
  • CDD Visualization is an intuitive browser-based application that allows scientists to visualize their data and generate publication-ready graphs and plots.
  • CDD is the provider of CDD Vault, a leading research informatics platform that includes solutions for Activity & Registration, ELN, and Inventory, in addition to Visualization.
  • CDD Vault has a long-standing policy of providing hundreds of open data sets on CDD Public as a service to the community.
  • "CDD Vault customers have long enjoyed the ability to securely manage, share, and analyze their research data in the platform," said Dr. Barry Bunin, CEO of CDD, "Now, for the first time, there is an opportunity for the entire scientific community to benefit from our technology through the open access CDD Visualization.

CDD Gives Back with Open Access Data Visualization Tool

Retrieved on: 
Thursday, October 7, 2021
SAR, Drug discovery, Algorithm, GitHub, FAIR, SAN, Open-source model, PubChem, Software, CDD, CDK, Activity, Pfizer, Subversive activities registration, ELN, Policy, Inventory, CEO, Solution, Informatics, Research, Technology

CDD Visualization is an intuitive browser-based application that allows scientists to visualize their data and generate publication-ready graphs and plots.

Key Points: 
  • CDD Visualization is an intuitive browser-based application that allows scientists to visualize their data and generate publication-ready graphs and plots.
  • CDD is the provider of CDD Vault, a leading research informatics platform that includes solutions for Activity & Registration, ELN, and Inventory, in addition to Visualization.
  • CDD Vault has a long-standing policy of providing hundreds of open data sets on CDD Public as a service to the community.
  • "CDD Vault customers have long enjoyed the ability to securely manage, share, and analyze their research data in the platform," said Dr. Barry Bunin, CEO of CDD, "Now, for the first time, there is an opportunity for the entire scientific community to benefit from our technology through the open access CDD Visualization.

AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx

Retrieved on: 
Wednesday, August 18, 2021
Publishing, DrugBank, Gans, Ranking SVM, Chemistry, Database, Biology, Drug discovery, CNN Philippines Nightly News, Latin, Absorption, Research, Rnn (software), Time, Drug design, AI, PubChem, SMILES, Subscription business model, Algorithm, De novo, 3D, Consultant, COVID-19, Technology, Drug development, Medical device

IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.

Key Points: 
  • IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.
  • For more information, please visit www.IDTechEx.com/AIDisc
    How is AI Used in Drug Discovery?
  • One of the most developed AI drug discovery technologies is its application in structure-based hit screening.
  • The application of AI in drug discovery is helping to tackle big challenges of time and cost in drug development.

AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx

Retrieved on: 
Wednesday, August 18, 2021
Publishing, DrugBank, Gans, Ranking SVM, Chemistry, Database, Biology, Drug discovery, CNN Philippines Nightly News, Latin, Absorption, Research, Rnn (software), Time, Drug design, AI, PubChem, SMILES, Subscription business model, Algorithm, De novo, 3D, Consultant, COVID-19, Technology, Drug development, Medical device

IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.

Key Points: 
  • IDTechEx have recently published a report, "AI in Drug Discovery 2021: Players, Technologies, and Applications" which covers this topic in detail.
  • For more information, please visit www.IDTechEx.com/AIDisc
    How is AI Used in Drug Discovery?
  • One of the most developed AI drug discovery technologies is its application in structure-based hit screening.
  • The application of AI in drug discovery is helping to tackle big challenges of time and cost in drug development.